Average Co-Inventor Count = 3.21
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Icahn School of Medicine at Mount Sinai (13 from 270 patents)
2. Mount Sinai School of Medicine (13 from 242 patents)
3. Genzyme Corporation (6 from 789 patents)
4. Alnylam Pharmaceuticals, Inc. (6 from 445 patents)
5. Other (1 from 832,880 patents)
6. The Brigham and Women's Hospital, Inc. (1 from 1,385 patents)
7. The Mount Sinai Medical Center (1 from 4 patents)
8. New York University (1,697 patents)
28 patents:
1. 11279977 - Materials and methods for identifying spinal muscular atrophy carriers
2. 11028392 - Compositions and methods for inhibiting expression of the ALAS1 gene
3. 10400239 - Compositions and methods for inhibiting expression of the ALAS1 gene
4. 10188705 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
5. 10125364 - Compositions and methods for inhibiting expression of the ALAS1 gene
6. 10119143 - Compositions and methods for inhibiting expression of the ALAS1 gene
7. 9994898 - Materials and methods for identifying spinal muscular atrophy carriers
8. 9655954 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
9. 9631193 - Compositions and methods for inhibiting expression of the ALAS1 gene
10. 9133461 - Compositions and methods for inhibiting expression of the ALAS1 gene
11. 9114139 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
12. 8709408 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
13. 8658162 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
14. 8349319 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
15. 7750050 - Chaperone-based therapy for Niemann-Pick disease